Introduction
Tumor necrosis factor (TNF) is a cytokine that mediates pleiotropic inflammatory and immunoregulatory responses via two distinct cell surface receptors of approximately 55 kDa (TNFRl) and 75 kDa (TNFR2) (reviewed by Tartaglia and Goeddel, 1992; Rothe et al., 1992; Vandenabeele et al., 1995) . Both TNFRs are members of the larger TNFR superfamily, which includes the Fas antigen, the lymphotoxin-8 receptor, CD40, and CD30, among others (reviewed by Smith et al., 1994) . Signaling within this receptor family is triggered by receptor clustering upon binding of the respective trimeric ligands to the conserved extracellular domains (reviewed by Tartaglia and Goeddel, 1992; Smith et al., 1994; Vandenabeele et al., 1995) . Similar to the related Fas antigen, TNFRl has been widely characterized to mediate TNF-induced apoptosis, also known as programmed cell death (reviewed by Smith et al., 1994) . This naturally occurring process of cell suicide plays a crucial role in the development and maintenance of multicellular organisms by eliminating superfluous or unwanted cells (reviewed by Raff, 1992) . Although TNFRP is capable of transducing apoptotic signals in certain cell lines (Grell et al., 1993) , ligation of TNFR2 by TNF does usually not trigger cell death. Rather, TNFR2 has been implicated in cell proliferation or survival, e.g., in thymocytes, where TNF-induced proliferation is specifically mediated by TNFR2 (Tartaglia et al., 1991 (Tartaglia et al., , 1993a .
The cytoplasmic domains of members of the TNFR family do not possess sequences indicative of catalytic activity, nor do they show resemblance to components of other known signal transduction pathways (reviewed by Tartaglia and Goeddel, 1992; Smith et al., 1994) . Elucidation of the intracellular events involved in signaling by TNF and related cytokines has begun to emerge from studies leading to the identification of several proteins that associate with the cytoplasmic domains of the cognate receptors (Rothe et al., 1994; Hu et al., 1994; Cheng et al., 1995; Mosialos et al., 1995; Sato et al., 1995a Sato et al., , 1995b Song and Donner, 1995; Hsu et al., 1995; Boldin et al., 1995; Chinnaiyan et al., 1995; Stanger et al., 1995) . TNFRassociated factor 1 (TRAFl) and 2 (TRAF2) were found to interact with a region within the cytoplasmic domain of TNFR2that is requiredforsignaltransduction (Rotheetal., 1994) . In the yeast two-hybrid system, TNFR2 associates directly with TRAF2, whereas its interaction with TRAFl is dependent upon TRAF2 heterocomplex formation. TRAF2 and a third TRAF family member, TRAFS, also bind to the cytoplasmic domain of CD40 and, presumably, other members of the TNFR superfamily (Hu et al., 1994; Cheng et al., 1995; Mosialoset al., 1995; Sato et al., 1995a; Rothe et al., 1995) . TRAFl and TRAF2 share a conserved C-terminal TRAF domain of approximately 230 amino acids that is involved in oligomerization and receptor association (Rothe et al., 1994) . Inspection of this region in TRAF3 identified two subdomains, the TRAF-C domain, comprising the C-terminal 150 amino acids, and the TRAF-N domain, which consists of a putative coiled coil (Cheng et al., 1995) . Whereas the TRAF-C domain is highly conserved among the three known TRAFs, the TRAF-N domain is diverged in TRAFS. In additon, TRAF2 and TRAFB contain an N-terminal RING finger and five zinc finger structures of weak sequence similarity (Rothe et al., 1994; Hu et al., 1994; Cheng et al., 1995; Mosialos et al., 1995; Sato et al., 1995a; Song and Donner, 1995) .
Both TNFR2 and CD40 can signal activation of the transcription factor NF-KB (Rothe et al., 1994; LEgreid et al., 1994; Berberich et al., 1994; Sarma et al., 1995) . Functional analysis demonstrated that TRAF2 is a common signal transducer for TNFR2 and CD40 that mediates activationof NF-KB bythesetwo receptors (Rotheetal., 1995) . This effector function of TRAF2 requires its N-terminal RING finger domain. The role of TRAFB in signal transduction is less well defined, but it has been implicated in CD40-mediated induction of CD23 (Cheng et al., 1995) .
Here we report the isolation and characterization of two novel components of the TNFR2 signaling complex, designated c-IAP1 and c-IAP2. Sequence analysis suggests that c-IAPl and c-IAP2 are cellular members of the baculoviral inhibitor of apoptosis protein (IAP) family. Biochemi- Large-scale purification of TNFRP-associated proteins from CT6 cells by GST-hTNF-RPicd fusion protein affinity chromatography was performed as described in Experimental
Procedures. An aliquot of the purified material was analyzed by SDS-PAGE and silver staining. The protein bands of 68 kDa and 66 kDa that were eluted specifically from the wild-type GST-hTNF-R2icd fusion protein affinity column compared with the control GST-hTNF-R2icd (-37) fusion protein column are marked. Arrows indicate the 45 kDa TRAFl band and the 56 kDa TRAFP band. Positions of molecular mass standards (in kilodaltons) are shown on the left.
cal studies indicate that both c-IAPs are recruited to TNFR2 via their interaction with a TRAF2-TRAW heterocomplex.
Results

Purification
and Molecular Cloning of the 66 kDa TNFRP-Associated Protein Previous biochemical analysis had identified three cytoplasmic proteins of approximately 45 kDa, 56 kDa, and 68 kDa that associate with a 78 amino acid C-terminal region of human TNFR2 (hTNFR2) involved in signaling (Rothe et al., 1994) . Subsequent large-scale purification, followed by partial amino acid sequencing and molecular cloning, led to the isolation of the cDNAs for TRAFl and TRAF2, corresponding to the 45 kDa and 58 kDa proteins, respectively (Rothe et al., 1994) . In contrast, the amount of 68 kDa TNFR2-associated protein initially purified was insufficient for generating partial amino acid sequence.
The 68 kDa TNFRP-associated protein was purified on a larger scale from 120 liters of murine CT6 cells by affinity chromatography using a fusion protein between glutathione S-transferase (GST) and the intracellular domain of hTNFR2 (GST-hTNF-RPicd)
as described in Experimental Procedures. The purification yielded two protein bands of approximately 88 kDa and 66 kDa (Figure 1 ; see also Freemont, 1993; Schwabeand Ktug, 1994) . Residues corresponding to the consensus sequence are stippled. Figure 2D in Rothe et al., 1994) . Both proteins were individually digested with proteases, and the amino acid sequence of internal peptideswasdetermined. Peptides with common sequences were found in the two proteins, suggesting that the 66 kDa protein may represent a degradation product or modification of the 68 kDa protein (data not shown). Fully degenerate oligonucleotides corresponding to two isolated peptides from the 68 kDa protein, YYIGPGD and EEMASGD, were used to amplify a 0.75 kb DNA fragment from mouse CT6 RNA by reverse transcription-polymerase chain reaction (RT-PCR). This DNA fragment was used to isolate a 2.85 kb cDNA clone from a mouse CT6 cDNA library. DNA sequence analysis of this cDNA clone revealed an open reading frame encoding a 612 amino acid protein with a predicted molecular mass of 69 kDa (Figure 2 Clem and Miller, 1994) . The 68 kDa protein was therefore designated cellular IAPl (c-IAPl), and we henceforth refer to its viral counterparts as v-IAPs.
Comparison of the primary structure of murine c-IAPl and v-IAPs indicates that they are composed of at least two distinct domains (Figures 2 and 3) . The N-terminal region of members of the IAP family contains characteristic tandem repeat units spanning approximately 70 amino acids that have been termed baculovirus IAP repeat (BIR) motifs (Birnbaum et al., 1994; Figures 3A and 3B) . Among v-IAPs, the BIR motifs of the IAP from Orgyia pseudotsugata nuclear polyhedrosis virus (OplAP; Birnbaum et al., 1994) are 68% and 30% identical with the equivalent domains of the IAPs from Cydia pomonella granulosis virus (CplAP; Crook et al., 1993) and from Autographa californica nuclear polyhedrosis virus (AclAP; Braunagel et al., 1992) , respectively ( Figure 38 ). The repeat motifs within the BIR domain of murine c-IAPl (amino acids l-329) share 50% amino acid identity with OplAP, 42% identity with CplAP, and 30% identity with AclAP ( Figure 3B ). In addition, c-IAPl displays 43% amino acid identity in its BIR motifs with the recently identified neuronal apoptosis inhibitory protein (NAIP) (Figure 38 ) a mammalian IAPrelated protein that has been implicated in spinal muscular atrophy disorders in humans (Roy et al., 1995) . The BIR motifs of NAIP show 33% identity with v-IAPs (Roy et al., 1995; Figure 38 ). This comparative analysis demonstrates that the BIR domains of mammalian c-IAPl and NAIP are roughly as closely related to the corresponding domains of v-IAPs as those are to one another, suggesting an evolutionary conserved function for this structural motif. However, whereas the BIR domains of known v-IAPs are comprised of two repeat motifs, mammalian c-IAPl and NAIP possess three tandem repeats (Figures 3A and 38) . The three BIR motifs of c-IAPl are 33% identical ( Figure 38 ).
The C-terminal domain of v-IAPs contains a RING finger motif (reviewed by Clem and Miller, 1994; Figures 3A and 3C) . This zinc-binding domain is also present in c-IAPl but missing in NAIP ( Figures 3A and 3C ). The RING finger domain of c-IAPl (amino acids 561-612) shares 42% and 36% identity over 52 amino acids with OplAP (or CplAP) and AclAP, respectively ( Figure 3C ). In comparison, the RING finger domains of OplAP and CplAP are 54% identical, whereas they exhibit only 25% identity with the RING finger domain of AclAP. RING finger structures have also been observed at the N-terminus of TRAF2 and TRAF3, where they mediate effector functions (Rothe et al., 1994 (Rothe et al., , 1995 Cheng et al., 1995) . Whereas the IAP RING finger motifs display a distribution of hydrophobic and charged residues that resembles several other RING finger family members (see Freemont, 1993) they do not share significant similarity with theTRAF RING finger domains beyond the conserved cysteine and histidine residues ( Figure 38 ). DNA probe under reduced hybridization stringency. Two distinct human cDNA clones of approximately 2.6 kb were isolated. One cDNA clone encoded a 70 kDa protein of 618 amino acids that is 84% identical to mouse c-IAPl, suggesting that it represents the human homolog of murine c-IAPl. The other human cDNA clone predicted a 68 kDa protein of 604 amino acids that is a second cellular member of the IAP family, termed c-IAP2. c-IAP2 is closely related to both murine and human c-IAPl, sharing 72% and 73% amino acid identity, respectively.
Like murine c-IAPl, human c-IAPl and c-IAP2 contain three N-terminal BIR motifs and a C-terminal RING finger domain (Figures 2 and 3) . In v-IAPs, these two domains are separated by a short linker region of approximately 30-50 amino acids (Clem and Miller, 1994) . In contrast, this region extends over roughly 230 amino acids in both murine and human c-IAPl (amino acids 330-560 and 337-566, respectively) as well as human c-IAP2 (amino acids 223-552) (see Figure 2 ). This protein domain displays strong sequence conservation among c-IAPs (87% identity between mouse and human c-IAPl and 70% identity between human c-IAPl and c-IAP2; see Figure 2 ) but does not bear any resemblance to v-IAPs nor to other known proteins.
The discovery of two closely related human IAPs along with their characterization as TNFR2-associated proteins (see below) suggests that the purified 66 kDa protein (see above) is probably the murine homolog of human c-IAP2 rather than a degradation product or modification of the purified 68 kDa protein.
Tissue Distribution of c-IA/J mRNA Northern blot analysis indicated that murine c-IAPl is the translation product of a 4.1 kb mRNA expressed constitutively in mouse tissues (heart, brain, spleen, lung, liver, skeletal muscle, kidney, and testis; Figure 4A ). Similarly, low levels of human c-IAP7 and c-IAP2 transcripts of approximately 4.3 kb and 6 kb, respectively, were detected in all human tissues examined (spleen, thymus, prostate, testis, ovary, small intestine, colon, and peripheral blood leukocytes; Figures 48 and 4C ). Human c-IAP7 mRNA was most abundant in thymus, testis, and ovary ( Figure  4B ), whereas human c-IAP2 expression was highest in spleen and thymus ( Figure 4C ).
The BIR Domains of c-IAPl and c-IAP2 Interact with the TRAF-N Domains of TRAFl and TRAFS Although the subsequent functional analysis of mammalian c-IAPs is described for c-IAPl only, virtually identical results were obtained for c-IAP2 (data not shown). Thus, functional distinction between these closely related members of the IAP family was not apparent.
The functional properties of c-IAPl as a TNFR2-associated protein were investigated in mammalian cells. Human c-IAPl containing an N-terminal Myc epitope was transiently expressed in human embryonic kidney 293 cells. Cell lysates were incubated with various GSThTNF-RPicd fusion proteins (Rothe et al., 1994) , and specific binding of c-IAPl was detected using an anti-Myc antibody. This analysis demonstrated that c-IAPl coprecipitates with GST fusion proteins containing the wild-type cytoplasmic domain of TNFR2 and the cytoplasmic domains of the functional receptor mutants hTNFR2 (-16) and hTNFR2(A304-345) ( Figure 5A ). However, c-IAPl did not coprecipitate with GST fusion proteins comprising the cytoplasmic domains of the inactive mutants hTNFR2(-37) and hTNFR2 (-59) ( Figure 5A ). These findings confirmed that the cloned c-IAPl corresponds to the endogenous 68 kDa TNFR2-associated protein and suggest that c-IAPl is involved in TNFR2 signaling.
Next we used the yeast two-hybrid system to determine whether the observed coprecipitation of c-IAPl and TNFR2 in cell extracts is mediated by direct association or via other TNFRSassociated proteins. Two-hybrid analysis ( Figure 6A ). These results indicate that the TRAF-N domain of TRAFP (amino acids 264-358) is required for interaction with c-IAPl. In contrast, the TRAF-C domain of TRAFP (amino acids 359-501) is essential for association with TNFR2 but dispensable for interaction with c-IAPl. Thus, c-IAPl and TNFR2 bind to nonoverlapping sites within the TRAF domain of TRAF2.
Whereas TRAFl and TRAFP can form homo-and heteromeric complexes, no homo-or heterodimerization of c-IAPl and c-IAP2 wasobserved either by two-hybrid analysis or coimmunoprecipitation experiments (data not shown). Mutational analysis of human c-IAPl was performed to investigate the structural requirements for its association with TRAFs. In the yeast two-hybrid system, the C-terminal RING finger domain of c-IAPl was expendable for interaction with TRAFs, since a mutant c-IAPl protein lacking this domain (c-IAPl [l-570])still associated with TRAFl and TRAF2 ( Figure 6A ). Further deletion analysis indicated that the region of c-IAPl containing the BIR motifs mediates the interaction with TRAFs, since a mutant c-IAPl protein comprising the N-terminal half of the molecule associated with TRAFl and TRAF2 whereas a mutant protein devoid of BIR motifs lacked this ability ( Figure 6A ). This observation suggests that BIR motifs of IAPs may constitute a protein-protein interaction domain.
c-IAPl and c-IAP2 Are Components of TNFRS-TRAF Signaling Complex
A transfection-based coimmunoprecipitation assay was used to further investigate the interaction of c-IAPl with components of the TNFR2-TRAF complex in mammalian cells. An expression vector encoding the Myc epitopetagged human c-IAPl was transfected alone or with expression vectors encoding FLAG epitope-tagged murine TRAFl orTRAF2 into 293 cells. Cell lysates were immunoprecipitated using a monoclonal antibody against the FLAG epitope, and coprecipitating c-IAPl was detected by immunoblotting with an anti-Myc monoclonal antibody. Both TRAFl and TRAF2 coprecipitated c-IAPl (see Figure  58 ). FLAG epitope-tagged murine c-IAPl was also able to coprecipitate hemagglutinin (HA) epitope-tagged human TRAF2 but not TRAFB (see Figure 5B ). Thus, as had been observed in the yeast two-hybrid system, c-IAPl associates with TRAFl and TRAF2 but not TRAF3 in mammalian cells. Similarly, the interaction of mutant c-IAPl and TRAF proteins in coprecipitation experiments confirmed the results obtained by two-hybrid analysis (data not shown).
Because the interaction between c-IAPl and TNFR2 was found to be indirect and both proteins bind to distinct regions within TRAF2, we reasoned that TRAF2 was likely to mediate the association of c-IAPl with TNFR2. Similarly, TRAF2 has been shown to mediate the interaction between TNFRP and TRAFl in the yeast two-hybrid system (Rothe et al., 1994) . To test this assumption, TNFR2 and Myc epitope-tagged c-IAPl were coexpressed in 293 cells in the absence or presence of overproduced TRAF proteins. Cell lysates were immunoprecipitated with polyclonal anti-TNFR2 antibodies, followed by immunoblotting with anti-Myc monoclonal antibody. In this assay, TNFR2 did not coprecipitate detectable levels of c-IAPl through endogenous factors since the amount of cell extract used for immunoprecipitation was approximately 25-fold less than in the coprecipitation experiments with GST-hTNFR2icd fusion proteins (see above) (see Figure 5C ). Surprisingly, coexpression of neither TRAFl norTRAF2 was sufficient to mediate association of TNFR2 with c-IAPl (see Figure 5C ). However, when equivalent amounts of both TRAFl and TRAF2 were coexpressed with TNFR2 and c-IAPl, strong coprecipitation of c-IAPl with TNFRP was detected (see Figure 5C ). This association of TNFR2 and c-IAPl was specifically mediated by the TRAFl-TRAF2 heterocomplex, since it was not observed upon coexpression of either TRAFl or TRAM with TRAFB (see Figure  5C ). These findings demonstrate that whereas c-IAPl is capable of associating directly with TRAFl and TRAF2, its interaction with TNFR2 is indirect and requires both TRAFl and TRAF2. c-IAP2 behaved indistinguishably from c-IAPl in this analysis (data not shown). Thus, both c-IAPl and c-IAP2 constitute components of the TNFR2 signaling complex.
Discussion
The recent identification of two distinct families of signal transducers has provided insights into how members of the TNFR superfamily initiate downstream signaling events (reviewed by Vandenabeele et al., 1995) . These signaling proteins contain either death domains or TRAF domains and are involved in signal transduction by either TNFRl and the Fas antigen or TNFR2, CD40, and, presumably, other TNFR family members, respectively. We now report the identification and molecular characterization of a third class of putative intracellular signal transducers for this diverse group of cell surface receptors. c-IAPl and c-IAP2 were found in association with the cytoplasmic domain of TNFR2 and are closely related mammalian members of the expanding IAP family originally identified in baculoviruses (Clem and Miller, 1994) .
The common structural feature of all IAP family members are tandem repeat units, termed BIR motifs, of the general consensus sequence XBRX20-23GX1,CX2CX16HXsCX3 (Birnbaum et al., 1994; Figure 38 ). The spacing of cysteine and histidine residues within the BIR motifs raises the possibility of metal ion coordination and nucleic acid binding, similar to known metal ion-containing protein motifs (Birnbaum et al., 1994) . Our mutational analysis of c-IAPl and c-IAP2 provides evidence that the BIR motif-containing domain of these two IAPs facilitates protein-protein interaction, allowing these proteins to associate with TRAFs. This finding suggests that other viral and cellular members of the IAP superfamily may interact with still unidentified TRAF-related proteins as part of their mechanism of action.
In addition to BIR motifs, all known IAP family members contain RING finger domains, with the exception of NAIP. This sequence motif has been observed in a wide variety of nuclear and cytoplasmic proteins and is thought to form two zinc-binding finger structures involved in protein-DNA interactions and possibly protein-protein interactions (reviewed by Schwabe and Klug, 1994) . Unlike most RING finger proteins characterized to date, the IAP RING finger domains are located C-terminally rather than N-terminally (Birnbaum et al., 1994) . N-terminal RING finger domains are also present in two members of the TRAF family, TRAFP and TRAF3 (Rothe et al., 1994; Hu et al., 1994; Cheng et al., 1995; Mosialos et al., 1995; Sato et al., 1995a; Song and Donner, 1995) . The TRAF2 RING finger domain is required for TRAFP-mediated NF-KB activation (Rothe et al., 1995) . By analogy, the RING finger domains of IAPs may represent effector or regulatory domains that are involved in IAP function.
Our analysis identifies c-IAPl and c-IAP2 as candidate signal transducers based on their association with a 78 amino acid region in TNFR2 cytoplasmic domain required for signaling (Rothe et al., 1994) . Both IAPs are recruited to TNFR2 by binding to a TRAF2-TRAFl heterocomplex. This indirect mode of interaction suggests that c-IAPl and c-IAP2 may be signaling molecules not only for TNFR2 but also for other members of the TNFR superfamily that bind the TRAF2-TRAFl heterocomplex (Rothe et al., 1995) . Also, these findings bear implications with respect to the function of TRAFl. Whereas TRAF2 and TRAF3 have each been linked to downstream signaling events, i.e., NF-KB activation (Rothe et al., 1995) and induction of CD23 expression (Cheng et al., 1995) respectively, a direct contribution of TRAFl to receptor signaling has not yet been uncovered. Our observations now support at least a structural role for TRAFl in the TNFR2 signaling complex by functioning as an adaptor protein that enables the recruitment of additional signaling proteins. Conceptually, TNFRP signaling appears to proceed via a multisubunit signaling complex, in which discrete intracellular signals may emanate from its individual components. Because expression of Tf?Af 7 transcripts is tissue specific (Rothe et al., 1994; Mosialos et al., 1995) , this model implies a mechanism for generating locally restricted responses upon ligand stimulation. In addition, TRAFl may also directly initiate signaling cascades distinct from TRAF2 and TRAFS.
Similar to its role in the development and maintenance of multicellularorganisms, apoptosis has been recognized as an efficient host antiviral defense mechanism through which virally infected cells are destroyed (reviewed by Vaux et al., 1994; Oltvai and Korsmeyer, 1994) . To ensure viral propagation, many DNA-containing viruses have evolved molecular strategies to circumvent and antagonize host death signals (reviewed by Oltvai and Korsmeyer, 1994; Vaux et al., 1994) . Among these anti-death mechanisms are virally acquired mimics of cellular proteins, such as BCLP, that regulate apoptosis during specific stages of host development (reviewed by Vaux et al., 1994; Oltvai and Korsmeyer, 1994) . However, several viral proteins have been identified that interfere with apoptosis, but for which putative cellular counterparts have remained elusive. Among these are the ~35 and IAP families from baculoviruses (reviewed by Clem and Miller, 1994) . Although initially isolated by genetic analysis in Spodoptera frugiperdacells, the ~35 protein was subsequentlydemonstrated to suppress apoptosis in Caenorhabditis elegans, Drosophila melanogaster, and mammalian cells (Sugimoto et al., 1994; Hay et al., 1994; Martinou et al., 1995; Beidler et al., 1995) . In contrast, functional analysis of baculoviral IAPs has been limited to insect cells.
Our discovery of two closely related mammalian members of the IAP family raises the possibility that c-IAPl and c-IAP2 function to regulate cellular apoptosis. (M. R., T. M. A., H. Hsu, and D. V. G., unpublished data) . Also, whereasv-IAPs have been shown to suppress apoptosis induced by actinomycin D in insect cells (Clem and Miller, 1994) , overexpression of c-IAPl or c-IAP2 did not antagonize actinomycin D-induced cell death in human HL60 cells (T. M. A. and M. R., unpublished data) . The finding that c-IAPI and c-IAP2 are most abundantly expressed in lymphoid tissues suggests that they may be involved in protecting against apoptosis initiated by other events in the immune system. In this respect, it appears possible that TNFR2-associated IAPs might participate in TNF-induced proliferation of thymocytes, since thisTNF response is specifically mediated byTNFR2 (Tartaglia et al., 1991 (Tartaglia et al., , 1993a .
Alternatively, c-IAPl and c-IAP2 may not contribute to the regulation of apoptosis. Unlike the closely related OplAP and CplAP, the AclAP does not sustain survival of infected insect cells (Birnbaum et al., 1994) . This apparent lack of apoptosis-antagonizing acitivity of AclAP may indicate functional diversity among viral and, by analogy, perhaps mammalian IAPs. In this respect, a potential involvment of c-IAPs in TRAFBmediated NF-KB activation by TNFR2 and CD40 was not substantiated (M. R. and D. V. G., unpublished data) . Thus, although our interaction analysis implicates an important role for c-IAPl and c-IAP2 in signaling by members of the TNFR superfamily, their specific function in this process remains to be elucidated. Similarly, the functional properties of viral AclAP await further studies. However, all IAP family members display highly conserved structural features, including BIR motifs and RING finger domains. This common architecture predicts equally conserved biochemical properties intrinsic to IAPs. To this end, our analysis represents a conceptual paradigm for the mechanism of action of members of the IAP family.
Experimental Procedures
Cell Culture and Biological Reagents The murine interleukin-2-dependent cytotoxic T cell line CT6 and human embryonic kidney 293 cells were maintained as described previously (Tartaglia et al., 1991; Pennica et al., 1992) . The rabbit antihTNFFi2 antibodies have been described previously (Pennica et al., 1992) . The monoclonal antibody QEIO against the Myc epitope was provided by Ft. Schreiber. The anti-FLAG epitope monoclonal antibody M2 and the anti-HA epitope monoclonal an!ibody 12CA5 were purchased from Eastman Kodak Company and BAbCO, respectively.
Purification and Amino Acid Sequencing of the 68 kDa TNFR2-Associated Protein Large-scale purification of the 66 kDa TNFR2-associated protein was performed according to previously described procedures (Rothe et al., 1994) . In brief, total cell extract prepared from 120 liters of CT6 cells (6 x 1O'O cells) was passed through a preabsorption column of 25 ml glutathione-agarose GST-hTNF-R2icd(-37) fusion protein. The flowthrough was applied to a 0.25 ml Affigel 10115 GST-hTNF-RPicd fusion protein affinity column. As a control, the lysate was passed through a similar Affigel lo/15 GST-hTNF-R2icd (-37) fusion protein affinity column in parallel. After extensive washing, bound proteins were eluted with ImmunoPure Gentle AglAb Elution Suffer (Pierce) containing 0.1 M DTT, precipitated with methanol/chloroform, and resuspended in SDS sample buffer containing 5% SDS. An aliquot of the material was separated by 6% SDS-PAGE under reducing conditions and visualized by silver staining. The remaining purified material was separated by SDS-PAGE and electrophoretically transfered to PVDF sequencing membrane (Millipore), and proteins were visualized by staining with Coomassie brilliant blue R-250 (Sigma). The proteins bands of 66 kDa and 66 kDa were cut out and subjected to amino acid sequencing as described previously (Rothe et al., 1994) . The labeled fragment was used to screen murine CT6 and human HeLa cDNA libraries (Rothe et al., 1994; Hsu et al., 1995) under standard high and reduced stringency conditions, respectively (Sambrook et al., 1989) . The cDNA inserts of positive phage clones were subcloned into pBluescript KS (Stratagene) and sequenced on both strands with Sequenase (United States Siochemical).
Northern blot analysis of mouse and human multiple tissue blots (Clontech) was done under high stringency conditions according to the instructions of the manufacturer with radiolabeled c-/API and c-IAP2 cDNA probes.
Yeast Two-Hybrid Assay DNA fragments encoding full-length and truncated variants of human c-IAPl and c-IAP2 were amplified from the corresponding cDNAs by PCR and cloned in-frame into the GAL4 DNA-binding domain vector pPC97 (Chevray and Nathans, 1992) . Expression vectors for TRAFs and the cytoplasmic domain of TNFR2 in the yeast two-hybrid system have been reported (Rothe et al., 1994; Hu et al., 1994) . Interaction analysis between bait-and prey-encoded fusion proteins in Saccharomyces cerevisiae Y190 cells was done as described by the manufacturer (Matchmaker Two-Hybrid System Protocol; Clontech).
Transfections, Coimmunoprecipitations, and lmmunoblotting For expression in mammalian cells, the cDNAs for murine and human c-IAP7 and human c-IAP2 were cloned into pRK5 under the transcriptional control of the cytomegalovirus immediate-early promotorenhancer (Schall et al., 1990) . Expression vectors for TNFRZ and TRAFs have been described previously (Tartaglia et al., 1993b; Hu et al., 1994; Rothe et al., 1995) . Epitope tag constructs were made by N-terminal addition of DNA encoding the sequences MASMEQKLI-SEEDL (Myc epitope tag) or MDYKDDDDK (FLAG epitope tag). For coprecipitation experiments with GST fusion proteins, 5 x lo6 293 cells per dish were seeded into 150 mm dishes and transfected the next day by the calcium phosphate precipitation method (Ausubel et al., 1967) . After incubation for 36 hr, cells were washed twice with phosphate-buffered saline and then lysed in 1 ml of 0.1% NP-40 lysis buffer containing 50 mM HEPES (pH 7.2) 250 mM NaCI, 10% glycerol, 2 mM EDTA, 1 mM PMSF, 1 Qglml benzamidine, 1 uglml aprotinin, 1 pglml leupeptin. Cell lysates were incubated for 2 hr at 4OC with 5 ul of glutathione-agarose GST-hTNF-RPicd fusion protein beads (Rothe et al., 1994 
